How Ozempic Maker Novo Nordisk Lost Its Shine

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes. continue reading...

Author
The New York Times